FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2896932089> ?p ?o ?g. }

• W2896932089 abstract "The Alberta Depression Research Priority Setting Project aimed to meaningfully involve patients, families and clinicians in determining a research agenda aligned to the needs of Albertans who have experienced depression. The project was modeled after a process developed in the UK by the James Lind Alliance and adapted to fit the Alberta, Canada context. This study describes the processes used to ensure the voices of people with lived experience of depression were integrated throughout the project stages. The year long project culminated with a facilitated session to identify the top essential areas of depression research focus. People with lived experience were engaged as part of the project’s Steering Committee, as survey participants and as workshop participants. It is hoped this process will guide future priority setting opportunities and advance depression research in Alberta. Background The Depression Research Priority Setting (DRPS) project has the clear aim of describing the patient engagement process used to identify depression research priorities and to reflect on the successes of this engagement approach, positive impacts and opportunities for improvement. To help support patient-oriented depression research priority setting in Alberta, the Patient Engagement (PE) Platform of the Alberta Strategy for Patient Oriented Research Support for People and Patient-Oriented Research and Trials (SUPPORT) Unit designed, along with the support of their partners in addictions and mental health, an explit process to engage patients in the design and execution of the DRPS. Methods The UK’s James Lind Alliance (JLA) Priority Setting Partnership (PSP) method was adapted into a six step process to ensure voices of “people with lived experience” (PWLE) with depression were included throughout the project stages. This study uses an explicit and parallel patient engagement process throughout each estage of the PSP designed by the PE Platform. Patient engagement was divided into a five step process: i) Awareness and relationship building; ii) Co-designing and co-developing a shared decision making process; iii) Collaborative communication; iv) Collective sensemaking; and v) Acknowledgement, celebration and recognition. A formative evaluation of the six PE processes was undertaken to explore the success of the parallel patient engagement process. Results This project was successful in engaging people with lived depression experience as partners in research priority setting, incorporating their voices into the discussions and decisions that led to the top 25 depression research questions. Conclusions The DRPS project has positively contributed to depression research in Canada by identifying the priorities of Albertans who have experienced depression for depression research. Dissemination activities to promote further knowledge exchange of prioritized research questions, with emphasis on the importance of process in engaging the voices of PWLE of depression are planned." @default.
• W2896932089 created "2018-10-26" @default.
• W2896932089 creator A5001397619 @default.
• W2896932089 creator A5003760300 @default.
• W2896932089 creator A5004419573 @default.
• W2896932089 creator A5008487808 @default.
• W2896932089 creator A5017709656 @default.
• W2896932089 creator A5018127981 @default.
• W2896932089 creator A5025174383 @default.
• W2896932089 creator A5027143136 @default.
• W2896932089 creator A5033548138 @default.
• W2896932089 creator A5034462006 @default.
• W2896932089 creator A5035867486 @default.
• W2896932089 creator A5047599529 @default.
• W2896932089 creator A5059755263 @default.
• W2896932089 creator A5064280799 @default.
• W2896932089 creator A5067482667 @default.
• W2896932089 creator A5072842504 @default.
• W2896932089 date "2018-10-16" @default.
• W2896932089 modified "2023-10-06" @default.
• W2896932089 title "People with lived experience (PWLE) of depression: describing and reflecting on an explicit patient engagement process within depression research priority setting in Alberta, Canada" @default.
• W2896932089 cites W1481876484 @default.
• W2896932089 cites W1840652611 @default.
• W2896932089 cites W1845252898 @default.
• W2896932089 cites W1919646544 @default.
• W2896932089 cites W1966170367 @default.
• W2896932089 cites W1969739188 @default.
• W2896932089 cites W1978013793 @default.
• W2896932089 cites W1986748932 @default.
• W2896932089 cites W2001949601 @default.
• W2896932089 cites W2011655883 @default.
• W2896932089 cites W2027343495 @default.
• W2896932089 cites W2064420378 @default.
• W2896932089 cites W2074681249 @default.
• W2896932089 cites W2077730482 @default.
• W2896932089 cites W2096611776 @default.
• W2896932089 cites W2100905299 @default.
• W2896932089 cites W2101633096 @default.
• W2896932089 cites W2111834230 @default.
• W2896932089 cites W2112728637 @default.
• W2896932089 cites W2112801915 @default.
• W2896932089 cites W2131575393 @default.
• W2896932089 cites W2133505056 @default.
• W2896932089 cites W2135850938 @default.
• W2896932089 cites W2145225199 @default.
• W2896932089 cites W2147355894 @default.
• W2896932089 cites W2179250674 @default.
• W2896932089 cites W2236587753 @default.
• W2896932089 cites W2283728052 @default.
• W2896932089 cites W2309603616 @default.
• W2896932089 cites W2321446101 @default.
• W2896932089 cites W2345358560 @default.
• W2896932089 cites W2464457728 @default.
• W2896932089 cites W2471250788 @default.
• W2896932089 cites W2515754279 @default.
• W2896932089 cites W2524575522 @default.
• W2896932089 cites W2532292930 @default.
• W2896932089 cites W2540766794 @default.
• W2896932089 cites W2552435993 @default.
• W2896932089 cites W2570435623 @default.
• W2896932089 cites W2577612100 @default.
• W2896932089 cites W2593766182 @default.
• W2896932089 cites W2604542916 @default.
• W2896932089 cites W2612811682 @default.
• W2896932089 cites W2739751169 @default.
• W2896932089 cites W2753862323 @default.
• W2896932089 cites W2794372865 @default.
• W2896932089 cites W2802993040 @default.
• W2896932089 cites W2894088909 @default.
• W2896932089 cites W4232698832 @default.
• W2896932089 cites W4238856797 @default.
• W2896932089 cites W759028320 @default.
• W2896932089 cites W895894219 @default.
• W2896932089 doi "https://doi.org/10.1186/s40900-018-0115-1" @default.
• W2896932089 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6190547" @default.
• W2896932089 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30349739" @default.
• W2896932089 hasPublicationYear "2018" @default.
• W2896932089 type Work @default.
• W2896932089 sameAs 2896932089 @default.
• W2896932089 citedByCount "17" @default.
• W2896932089 countsByYear W28969320892019 @default.
• W2896932089 countsByYear W28969320892020 @default.
• W2896932089 countsByYear W28969320892021 @default.
• W2896932089 countsByYear W28969320892022 @default.
• W2896932089 countsByYear W28969320892023 @default.
• W2896932089 crossrefType "journal-article" @default.
• W2896932089 hasAuthorship W2896932089A5001397619 @default.
• W2896932089 hasAuthorship W2896932089A5003760300 @default.
• W2896932089 hasAuthorship W2896932089A5004419573 @default.
• W2896932089 hasAuthorship W2896932089A5008487808 @default.
• W2896932089 hasAuthorship W2896932089A5017709656 @default.
• W2896932089 hasAuthorship W2896932089A5018127981 @default.
• W2896932089 hasAuthorship W2896932089A5025174383 @default.
• W2896932089 hasAuthorship W2896932089A5027143136 @default.
• W2896932089 hasAuthorship W2896932089A5033548138 @default.
• W2896932089 hasAuthorship W2896932089A5034462006 @default.
• W2896932089 hasAuthorship W2896932089A5035867486 @default.
• W2896932089 hasAuthorship W2896932089A5047599529 @default.
• W2896932089 hasAuthorship W2896932089A5059755263 @default.
• W2896932089 hasAuthorship W2896932089A5064280799 @default.

• next